Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2644 | 3490 | 35.1 | 69% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
365 | 3 | MICROTUBULES//MITOSIS//KINETOCHORE | 34118 |
2644 | 2 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 3490 |
5476 | 1 | COMBRETASTATIN//COMBRETASTATIN A 4//VASCULAR DISRUPTING AGENTS | 1619 |
14569 | 1 | THIOCOLCHICOSIDE//COLCHICINOIDS//THIOCOLCHICINE | 762 |
20741 | 1 | COLCHICINE//COLCHICINE POISONING//COLCHICUM AUTUMNALE | 447 |
22006 | 1 | DMXAA//FLAVONE ACETIC ACID//5 6 DIMETHYLXANTHENONE 4 ACETIC ACID | 397 |
31212 | 1 | INDUCTIVE LABILITY//LABILE STATE//PERIPHERAL IMMUNE RESPONSES | 156 |
34573 | 1 | CI 980//1 ACETYLINDOLINE//ALPHA AMINOALKYL ARYL KETONE | 109 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COMBRETASTATIN | authKW | 1076470 | 4% | 89% | 139 |
2 | COMBRETASTATIN A 4 | authKW | 762646 | 3% | 75% | 117 |
3 | VASCULAR DISRUPTING AGENTS | authKW | 641612 | 3% | 65% | 112 |
4 | COLCHICINE | authKW | 583498 | 9% | 20% | 331 |
5 | DMXAA | authKW | 400891 | 1% | 88% | 52 |
6 | FLAVONE ACETIC ACID | authKW | 233502 | 1% | 86% | 31 |
7 | SCREENING TECHNOL BRANCH | address | 197423 | 2% | 31% | 73 |
8 | CANC TREATMENT DIAGFREDERICK CANC | address | 194388 | 1% | 67% | 33 |
9 | TUBULIN | authKW | 191892 | 6% | 10% | 218 |
10 | PHENSTATIN | authKW | 183698 | 1% | 100% | 21 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 25035 | 25% | 0% | 885 |
2 | Oncology | 4882 | 21% | 0% | 726 |
3 | Chemistry, Organic | 3513 | 16% | 0% | 544 |
4 | Pharmacology & Pharmacy | 3079 | 19% | 0% | 673 |
5 | Biochemistry & Molecular Biology | 617 | 15% | 0% | 537 |
6 | Chemistry, Multidisciplinary | 223 | 8% | 0% | 291 |
7 | Toxicology | 151 | 3% | 0% | 97 |
8 | Rheumatology | 59 | 1% | 0% | 37 |
9 | Chemistry, Analytical | 39 | 3% | 0% | 107 |
10 | Biochemical Research Methods | 30 | 2% | 0% | 70 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SCREENING TECHNOL BRANCH | 197423 | 2% | 31% | 73 |
2 | CANC TREATMENT DIAGFREDERICK CANC | 194388 | 1% | 67% | 33 |
3 | CANC TREATMENT DIAGNIH | 119495 | 1% | 33% | 41 |
4 | DEV THER EUT PROGRAMNIH | 96421 | 1% | 53% | 21 |
5 | AUCKLAND CANC SOC | 89675 | 2% | 13% | 81 |
6 | UNITE BIOTECHNOL BIOINGN | 62187 | 0% | 44% | 16 |
7 | ONCOEMATOL | 48593 | 0% | 33% | 17 |
8 | DEV THER EUT PROGRAM | 37801 | 2% | 6% | 69 |
9 | LP4 | 36446 | 0% | 83% | 5 |
10 | UNITA ONCOL SPERIMENTALE IMMUNOL | 34990 | 0% | 100% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF MEDICINAL CHEMISTRY | 13586 | 5% | 1% | 184 |
2 | BIOORGANIC & MEDICINAL CHEMISTRY | 12282 | 4% | 1% | 136 |
3 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 7311 | 3% | 1% | 89 |
4 | ANTI-CANCER DRUG DESIGN | 5000 | 1% | 3% | 19 |
5 | INVESTIGATIONAL NEW DRUGS | 4885 | 1% | 1% | 38 |
6 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 4337 | 2% | 1% | 61 |
7 | MEDCHEMCOMM | 4007 | 1% | 2% | 25 |
8 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 3961 | 3% | 0% | 109 |
9 | CHEMMEDCHEM | 3854 | 1% | 1% | 32 |
10 | BRITISH JOURNAL OF CANCER | 2149 | 2% | 0% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMBRETASTATIN | 1076470 | 4% | 89% | 139 | Search COMBRETASTATIN | Search COMBRETASTATIN |
2 | COMBRETASTATIN A 4 | 762646 | 3% | 75% | 117 | Search COMBRETASTATIN+A+4 | Search COMBRETASTATIN+A+4 |
3 | VASCULAR DISRUPTING AGENTS | 641612 | 3% | 65% | 112 | Search VASCULAR+DISRUPTING+AGENTS | Search VASCULAR+DISRUPTING+AGENTS |
4 | COLCHICINE | 583498 | 9% | 20% | 331 | Search COLCHICINE | Search COLCHICINE |
5 | DMXAA | 400891 | 1% | 88% | 52 | Search DMXAA | Search DMXAA |
6 | FLAVONE ACETIC ACID | 233502 | 1% | 86% | 31 | Search FLAVONE+ACETIC+ACID | Search FLAVONE+ACETIC+ACID |
7 | TUBULIN | 191892 | 6% | 10% | 218 | Search TUBULIN | Search TUBULIN |
8 | PHENSTATIN | 183698 | 1% | 100% | 21 | Search PHENSTATIN | Search PHENSTATIN |
9 | ZD6126 | 177124 | 1% | 75% | 27 | Search ZD6126 | Search ZD6126 |
10 | TUBULIN POLYMERIZATION | 171336 | 1% | 38% | 52 | Search TUBULIN+POLYMERIZATION | Search TUBULIN+POLYMERIZATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GREENE, LM , MEEGAN, MJ , ZISTERER, DM , (2015) COMBRETASTATINS: MORE THAN JUST VASCULAR TARGETING AGENTS?.JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. VOL. 355. ISSUE 2. P. 212 -227 | 160 | 83% | 8 |
2 | PEREZ-PEREZ, MJ , PRIEGO, EM , BUENO, O , MARTINS, MS , CANELA, MD , LIEKENS, S , (2016) BLOCKING BLOOD FLOW TO SOLID TUMORS BY DESTABILIZING TUBULIN: AN APPROACH TO TARGETING TUMOR GROWTH.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 19. P. 8685 -8711 | 141 | 71% | 3 |
3 | KRETZSCHMANN, VK , FURST, R , (2014) PLANT-DERIVED VASCULAR DISRUPTING AGENTS: COMPOUNDS, ACTIONS, AND CLINICAL TRIALS.PHYTOCHEMISTRY REVIEWS. VOL. 13. ISSUE 1. P. 191-206 | 107 | 86% | 14 |
4 | RAJAK, H , DEWANGAN, PK , PATEL, V , JAIN, DK , SINGH, A , VEERASAMY, R , SHARMA, PC , DIXIT, A , (2013) DESIGN OF COMBRETASTATIN A-4 ANALOGS AS TUBULIN TARGETED VASCULAR DISRUPTING AGENT WITH SPECIAL EMPHASIS ON THEIR CIS-RESTRICTED ISOMERS.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 10. P. 1923-1955 | 112 | 78% | 18 |
5 | LU, Y , CHEN, JJ , XIAO, M , LI, W , MILLER, DD , (2012) AN OVERVIEW OF TUBULIN INHIBITORS THAT INTERACT WITH THE COLCHICINE BINDING SITE.PHARMACEUTICAL RESEARCH. VOL. 29. ISSUE 11. P. 2943 -2971 | 100 | 66% | 122 |
6 | TRON, GC , PIRALI, T , SORBA, G , PAGLIAI, F , BUSACCA, S , GENAZZANI, AA , (2006) MEDICINAL CHEMISTRY OF COMBRETASTATIN A4: PRESENT AND FUTURE DIRECTIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 49. ISSUE 11. P. 3033-3044 | 82 | 85% | 344 |
7 | TOZER, GM , KANTHOU, C , BAGULEY, BC , (2005) DISRUPTING TUMOUR BLOOD VESSELS.NATURE REVIEWS CANCER. VOL. 5. ISSUE 6. P. 423-435 | 96 | 66% | 553 |
8 | CHAUDHARY, A , PANDEYA, SN , KUMAR, P , SHARMA, P , GUPTA, S , SONI, N , VERMA, KK , BHARDWAJ, G , (2007) COMBRETASTATIN A-4 ANALOGS AS ANTICANCER AGENTS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 12. P. 1186-1205 | 98 | 89% | 80 |
9 | PATIL, PO , PATIL, AG , RANE, RA , PATIL, PC , DESHMUKH, PK , BARI, SB , PATIL, DA , NAPHADE, SS , (2015) RECENT ADVANCEMENT IN DISCOVERY AND DEVELOPMENT OF NATURAL PRODUCT COMBRETASTATIN-INSPIRED ANTICANCER AGENTS.ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 8. P. 955 -969 | 81 | 94% | 5 |
10 | ALVAREZ, R , ARAMBURU, L , PUEBLA, P , CABALLERO, E , GONZALEZ, M , VICENTE, A , MEDARDE, M , PELAEZ, R , (2016) PYRIDINE BASED ANTITUMOUR COMPOUNDS ACTING AT THE COLCHICINE SITE.CURRENT MEDICINAL CHEMISTRY. VOL. 23. ISSUE 11. P. 1100 -1130 | 136 | 59% | 0 |
Classes with closest relation at Level 2 |